Cargando…

The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease

Pulmonary vascular resistance (PVR) is traditionally used to describe pulmonary hemodynamic characteristics. However, it does not take into account pulmonary artery compliance (Ca) or pulsatile flow. The product of PVR and Ca is known as RC time. Previous studies assert that the PVR-Ca relationship...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hadinnapola, Charaka, Li, Qiuju, Su, Li, Pepke-Zaba, Joanna, Toshner, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425968/ https://www.ncbi.nlm.nih.gov/pubmed/25902784 http://dx.doi.org/10.14814/phy2.12363

Ejemplares similares

Chronic thromboembolic pulmonary hypertension: time for research in pathophysiology to catch up with developments in treatment
por: Toshner*, Mark, et al.
Publicado: (2014)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

The prognostic ability of cardiac output determined by inert gas rebreathing technique in pulmonary hypertension
por: Robertson, Lucy, et al.
Publicado: (2022)

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension
por: Rhodes, Christopher J., et al.
Publicado: (2017)

A minimal clinically important difference measured by the Cambridge Pulmonary Hypertension Outcome Review for patients with idiopathic pulmonary arterial hypertension
por: Bunclark, Katherine, et al.
Publicado: (2021)

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience
por: Hoole, Stephen P, et al.
Publicado: (2020)

The ADAMTS13–VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension
por: Newnham, Michael, et al.
Publicado: (2019)

Medical management of chronic thromboembolic pulmonary hypertension
por: Pepke-Zaba, Joanna, et al.
Publicado: (2017)

Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertension
por: Soon, Elaine, et al.
Publicado: (2011)

Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis
por: Owen, Nicola E., et al.
Publicado: (2020)

Relationship between compliance and pulmonary vascular resistance in pulmonary arterial hypertension
por: Guigui, Sarah, et al.
Publicado: (2020)

Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?
por: Florczyk, Michał, et al.
Publicado: (2017)

Medication and patient factors associated with adherence to pulmonary hypertension targeted therapies
por: Grady, Duncan, et al.
Publicado: (2017)

Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension
por: Swietlik, Emilia M., et al.
Publicado: (2021)

Quality of life in patients with chronic thromboembolic pulmonary hypertension
por: Mathai, Stephen C., et al.
Publicado: (2016)

Balloon pulmonary angioplasty outcomes in patients previously treated by pulmonary endarterectomy surgery are inferior to those of inoperable patients
por: Kirkby, Louise C., et al.
Publicado: (2023)

Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension
por: Khan, Akram, et al.
Publicado: (2022)

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
por: Belge, Catharina, et al.
Publicado: (2020)

Maximal Cardiac Output Determines 6 Minutes Walking Distance in Pulmonary Hypertension
por: Deboeck, Gaël, et al.
Publicado: (2014)

Author's reply
por: Pepke-Zaba, Joanna
Publicado: (2012)

Acute lung injury after balloon pulmonary angioplasty results in a similar haemodynamic response and possible clinical advantage at follow‐up
por: Rodgers, Matthew S., et al.
Publicado: (2022)

Presentation and management of pulmonary artery sarcoma
por: Wong, Han Hsi, et al.
Publicado: (2015)

Isolated large vessel pulmonary vasculitis as a cause of chronic obstruction of the pulmonary arteries
por: Hagan, Guy, et al.
Publicado: (2011)

Endothelin ET(A) receptors predominate in chronic thromboembolic pulmonary hypertension
por: Southwood, Mark, et al.
Publicado: (2016)

Ventriculo‐arterial coupling detects occult RV dysfunction in chronic thromboembolic pulmonary vascular disease
por: Axell, Richard G., et al.
Publicado: (2017)

Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries
por: Schweikert, Bernd, et al.
Publicado: (2014)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

Lowering Pulmonary Wedge Pressure after Heart Transplant: Pulmonary Compliance and Resistance Effect
por: Moreira, Nádia, et al.
Publicado: (2015)

Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021
por: Simonneau, Gérald, et al.
Publicado: (2023)

Pulmonary hypertension in chronic lung disease and hypoxia
por: Nathan, Steven D., et al.
Publicado: (2019)

Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
por: Wu, Yanjuan, et al.
Publicado: (2023)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
por: Bhamani, Amyn, et al.
Publicado: (2019)

(18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study
por: Hagan, Guy, et al.
Publicado: (2011)

Repurposing of medications for pulmonary arterial hypertension
por: Toshner, Mark, et al.
Publicado: (2020)

Change in pulmonary arterial compliance and pulmonary pulsatile stress after balloon pulmonary angioplasty
por: Akaslan, Dursun, et al.
Publicado: (2021)

Echocardiographic assessment of pulmonary vascular resistance in pulmonary arterial hypertension
por: Roule, Vincent, et al.
Publicado: (2010)

Management of systemic to pulmonary shunts and elevated pulmonary vascular resistance
por: Linder, Alexandra N., et al.
Publicado: (2023)

Improvement of pulmonary arterial compliance by pulmonary vasodilator in pulmonary hypertension from combined pulmonary fibrosis and emphysema
por: Kusaka, Kei, et al.
Publicado: (2019)

Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f6vphp6md2fo4d9g8nrqedvau0